Oncolytics Biotech Inc. Files April 2025 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Apr 11, 2025 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, regulatory-update
Related Tickers: ONCY
TL;DR
ONCY files routine 6-K for April 2025, standard foreign private issuer update.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on April 11, 2025, reporting for the month of April 2025. The company is a foreign private issuer based in Calgary, Alberta, Canada, and is subject to the 1934 Securities Exchange Act. Oncolytics Biotech Inc. is classified under the Pharmaceutical Preparations industry.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding Oncolytics Biotech Inc.'s status as a foreign private issuer.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain specific financial or operational news that would indicate a change in risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer
- April 2025 (date) — Reporting period
- 001-38512 (other) — SEC File Number
- Calgary, Alberta, Canada (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC to provide information that the issuer makes or is required to make public in its home country, files or makes public with any stock exchange on which its securities are traded, or distributes or makes public to its security holders.
What is the filing date of this Form 6-K?
This Form 6-K was filed as of April 11, 2025.
What is the reporting period for this Form 6-K?
The report is for the month of April 2025.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
Under which SEC Act is this filing made?
This filing is made pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 11, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).